echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 500 million oral hypoglycemic drugs in East China all specifications have been reviewed!

    500 million oral hypoglycemic drugs in East China all specifications have been reviewed!

    • Last Update: 2021-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, Huadong Medicine welcomes good news in the field of oral hypoglycemic drugs.


    Figure 1: Information of Huadong Medicine's over-evaluated products

    Source: NMPA official website

    Pioglitazone hydrochloride tablets are thiazolidinedione insulin sensitizers, which mainly reduce blood sugar by increasing the sensitivity of target cells to insulin


    Figure 2: Sales of pioglitazone hydrochloride tablets

    Source: Mi Nei.


    According to data from Meinenet, in the last three years, the sales of pioglitazone hydrochloride tablets in China’s urban public hospitals, county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) have remained above 500 million yuan in 2020.


    Figure 3: East China's next blockbuster oral hypoglycemic drug approved

    Source: Meinenet MED2.


    In June of this year, East China's Metformin Enpagliflozin Tablets (I) was approved for the first imitation, adding a major player to the company's oral hypoglycemic product line


    Source: CDE official website, Minet database

    The review data statistics are as of August 20, if there are any errors or omissions, please correct me


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.